Instil Bio, Inc. Contracts & Agreements
20 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (1)
- Human Resources (12)
- Uncategorized (1)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 21, 2024)
- Form of Retention Bonus Agreement (Filed With SEC on February 14, 2024)
- Separation Agreement, by and between the Registrant and Sumita Ray, dated as of April 14, 2023 (Filed With SEC on August 14, 2023)
- Retention Bonus (Filed With SEC on May 11, 2023)
- Retention Bonus Agreement, by and between the Registrant and Bronson Crouch, dated as of February 22, 2023 (Filed With SEC on May 11, 2023)
- Form of Retention Bonus Agreement (Filed With SEC on February 27, 2023)
- Mezzanine Loan Agreement, by and between Complex Therapeutics Mezzanine LLC and OPG Hermes Investments (DE) LLC, dated June 10, 2022 (Filed With SEC on August 12, 2022)
- Loan Agreement, by and between Complex Therapeutics LLC and OPG Hermes Investments (DE) LLC, dated June 10, 2022 (Filed With SEC on August 12, 2022)
- Executive Employment Agreement by and between the Company and Vijay Chiruvolu effective as of July 17, 2021 (Filed With SEC on May 16, 2022)
- Description of Securities (Filed With SEC on March 7, 2022)
- Executive Employment Agreement, by and between the Registrant and Sandeep Laumas, M.D., dated as of June 2020 (Filed With SEC on March 15, 2021)
- Executive Employment Agreement, by and between the Registrant and Zachary Roberts, M.D., Ph.D., dated as of June 2020 (Filed With SEC on March 15, 2021)
- Executive Employment Agreement, by and between the Registrant and Bronson Crouch, dated as of June 2020 (Filed With SEC on March 15, 2021)
- Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on March 15, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on March 15, 2021)
- 2021 Equity Incentive Plan and Forms of Option Grant Notice and Agreement, Exercise Notice, Early Exercise Notice and Restricted Stock Award Notice (Filed With SEC on March 15, 2021)
- Form of Underwriting Agreement (Filed With SEC on March 15, 2021)
- Second Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated December 30, 2020 (Filed With SEC on February 26, 2021)
- 2018 Stock Incentive Plan and Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Exercise and Common Stock Purchase Agreement (Filed With SEC on February 26, 2021)
- Share Purchase Agreement, by and between the Registrant and Immetacyte Limited, dated March 2, 2020 (Filed With SEC on February 26, 2021)
